ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
SMC rejects two indications of myeloma drugs Kyprolis and Darzalex in Scotland
pharmaceutical-technology
January 18, 2017Drug approval body the Scottish Medicines Consortium (SMC) has rejected two life-prolonging indications of new myeloma drugs, Kyprolis (carfilzomib) and Darzalex (daratumumab), for use in the country.
Pharma Sources Insight July 2025
